NO20043009L - Substituerte imidazolidiner, fremgangsmate for fremstilling derav, deres anvendelse som et legemiddel eller for diagnose og legemiddel inneholdende substituerte imidazolidiner - Google Patents
Substituerte imidazolidiner, fremgangsmate for fremstilling derav, deres anvendelse som et legemiddel eller for diagnose og legemiddel inneholdende substituerte imidazolidinerInfo
- Publication number
- NO20043009L NO20043009L NO20043009A NO20043009A NO20043009L NO 20043009 L NO20043009 L NO 20043009L NO 20043009 A NO20043009 A NO 20043009A NO 20043009 A NO20043009 A NO 20043009A NO 20043009 L NO20043009 L NO 20043009L
- Authority
- NO
- Norway
- Prior art keywords
- medicament
- substituted imidazolidines
- diagnosis
- preparation
- imidazolidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10163239A DE10163239A1 (de) | 2001-12-21 | 2001-12-21 | Substituierte Imidazolidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie enthaltendes Medikament |
| PCT/EP2002/013921 WO2003053434A1 (de) | 2001-12-21 | 2002-12-09 | Substituierte imidazolidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie enthaltendes medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043009L true NO20043009L (no) | 2004-07-15 |
Family
ID=7710363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043009A NO20043009L (no) | 2001-12-21 | 2004-07-15 | Substituerte imidazolidiner, fremgangsmate for fremstilling derav, deres anvendelse som et legemiddel eller for diagnose og legemiddel inneholdende substituerte imidazolidiner |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1461034B1 (es) |
| JP (1) | JP4571803B2 (es) |
| KR (1) | KR100959031B1 (es) |
| CN (1) | CN100339079C (es) |
| AR (1) | AR037932A1 (es) |
| AT (1) | ATE345797T1 (es) |
| AU (1) | AU2002361990B2 (es) |
| BR (1) | BR0215154A (es) |
| CA (1) | CA2470856A1 (es) |
| CO (1) | CO5590925A2 (es) |
| DE (2) | DE10163239A1 (es) |
| DK (1) | DK1461034T3 (es) |
| ES (1) | ES2275945T3 (es) |
| HR (1) | HRP20040573A2 (es) |
| HU (1) | HUP0600836A2 (es) |
| IL (2) | IL162562A0 (es) |
| MA (1) | MA27149A1 (es) |
| MX (1) | MXPA04005388A (es) |
| MY (1) | MY134344A (es) |
| NO (1) | NO20043009L (es) |
| PE (1) | PE20030741A1 (es) |
| PL (1) | PL368940A1 (es) |
| RS (1) | RS53204A (es) |
| RU (1) | RU2004122415A (es) |
| TW (1) | TW200305408A (es) |
| WO (1) | WO2003053434A1 (es) |
| ZA (1) | ZA200404149B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10323701A1 (de) | 2003-05-22 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Verfahren zur Synthese heterocyclischer Verbindungen |
| US7632970B2 (en) | 2003-06-30 | 2009-12-15 | Sumitomo Chemical Company, Limited | Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
| DE10341240A1 (de) * | 2003-09-08 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| LT3173408T (lt) | 2014-07-25 | 2018-12-27 | Taisho Pharmaceutical Co., Ltd. | Fenilo tetrahidroizochinolino junginys, turintis heteroarilo pakaitų |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3236857A (en) * | 1961-10-09 | 1966-02-22 | Boehringer Sohn Ingelheim | 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products |
| US3202660A (en) * | 1961-10-09 | 1965-08-24 | Boehringer Sohn Ingelheim | Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes |
| EP0070084A3 (en) * | 1981-04-24 | 1983-02-16 | Beecham Group Plc | Imidazoline derivatives |
| DE3712385A1 (de) * | 1987-04-11 | 1988-10-27 | Boehringer Ingelheim Kg | 2-(phenylimino)imidazolidine |
| GB9313330D0 (en) * | 1993-06-28 | 1993-08-11 | Fujisawa Pharmaceutical Co | New compound and its preparation |
| EP0639573A1 (de) * | 1993-08-03 | 1995-02-22 | Hoechst Aktiengesellschaft | Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament |
| DE4328869A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| KR100257129B1 (ko) * | 1993-09-11 | 2000-05-15 | 성재갑 | 신규 세팔로스포린계 항생제 및 이의 제조방법 |
| US5552415A (en) * | 1993-12-21 | 1996-09-03 | Eli Lilly And Company | Method of inhibiting Alzheimer's Disease |
| DE19548812A1 (de) * | 1995-12-27 | 1997-07-03 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation |
| DE19633966A1 (de) * | 1996-08-22 | 1998-02-26 | Hoechst Ag | Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DK0966465T3 (da) * | 1997-03-14 | 2003-10-20 | Vertex Pharma | Inhibitorer af IMPDH-enzymer |
| DE19945302A1 (de) * | 1999-09-22 | 2001-03-29 | Merck Patent Gmbh | Biphenylderivate als NHE-3-Inhibitoren |
| DE19950898A1 (de) * | 1999-10-22 | 2001-04-26 | Aventis Pharma Gmbh | Heterocyclisch substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19960204A1 (de) * | 1999-12-14 | 2001-06-28 | Aventis Pharma Gmbh | Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE10015248A1 (de) * | 2000-03-28 | 2001-10-04 | Merck Patent Gmbh | Bisamidino-Verbindungen als NHE-3 Inhibitoren |
| DE10019062A1 (de) * | 2000-04-18 | 2001-10-25 | Merck Patent Gmbh | 2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren |
| DE10060292A1 (de) * | 2000-12-05 | 2002-06-20 | Aventis Pharma Gmbh | Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament |
-
2001
- 2001-12-21 DE DE10163239A patent/DE10163239A1/de not_active Withdrawn
-
2002
- 2002-12-09 EP EP02796586A patent/EP1461034B1/de not_active Expired - Lifetime
- 2002-12-09 ES ES02796586T patent/ES2275945T3/es not_active Expired - Lifetime
- 2002-12-09 MX MXPA04005388A patent/MXPA04005388A/es active IP Right Grant
- 2002-12-09 RS YU53204A patent/RS53204A/sr unknown
- 2002-12-09 CA CA002470856A patent/CA2470856A1/en not_active Abandoned
- 2002-12-09 RU RU2004122415/04A patent/RU2004122415A/ru not_active Application Discontinuation
- 2002-12-09 BR BR0215154-5A patent/BR0215154A/pt not_active IP Right Cessation
- 2002-12-09 AT AT02796586T patent/ATE345797T1/de not_active IP Right Cessation
- 2002-12-09 AU AU2002361990A patent/AU2002361990B2/en not_active Ceased
- 2002-12-09 CN CNB028258177A patent/CN100339079C/zh not_active Expired - Fee Related
- 2002-12-09 JP JP2003554191A patent/JP4571803B2/ja not_active Expired - Fee Related
- 2002-12-09 WO PCT/EP2002/013921 patent/WO2003053434A1/de active IP Right Grant
- 2002-12-09 KR KR1020047009820A patent/KR100959031B1/ko not_active IP Right Cessation
- 2002-12-09 PL PL02368940A patent/PL368940A1/xx not_active Application Discontinuation
- 2002-12-09 IL IL16256202A patent/IL162562A0/xx unknown
- 2002-12-09 DE DE50208809T patent/DE50208809D1/de not_active Expired - Lifetime
- 2002-12-09 HU HU0600836A patent/HUP0600836A2/hu unknown
- 2002-12-09 DK DK02796586T patent/DK1461034T3/da active
- 2002-12-11 PE PE2002001194A patent/PE20030741A1/es not_active Application Discontinuation
- 2002-12-19 AR ARP020105018A patent/AR037932A1/es unknown
- 2002-12-19 TW TW091136596A patent/TW200305408A/zh unknown
- 2002-12-20 MY MYPI20024821A patent/MY134344A/en unknown
-
2004
- 2004-05-27 ZA ZA200404149A patent/ZA200404149B/en unknown
- 2004-06-01 MA MA27709A patent/MA27149A1/fr unknown
- 2004-06-16 IL IL162562A patent/IL162562A/en not_active IP Right Cessation
- 2004-06-17 CO CO04056920A patent/CO5590925A2/es not_active Application Discontinuation
- 2004-06-18 HR HR20040573A patent/HRP20040573A2/hr not_active Application Discontinuation
- 2004-07-15 NO NO20043009A patent/NO20043009L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE345797T1 (de) | 2006-12-15 |
| AR037932A1 (es) | 2004-12-22 |
| HRP20040573A2 (en) | 2004-10-31 |
| PE20030741A1 (es) | 2003-09-29 |
| IL162562A0 (en) | 2005-11-20 |
| EP1461034B1 (de) | 2006-11-22 |
| ZA200404149B (en) | 2006-05-31 |
| CN1606440A (zh) | 2005-04-13 |
| DE10163239A1 (de) | 2003-07-10 |
| AU2002361990A1 (en) | 2003-07-09 |
| KR20040068322A (ko) | 2004-07-30 |
| MY134344A (en) | 2007-12-31 |
| PL368940A1 (en) | 2005-04-04 |
| CA2470856A1 (en) | 2003-07-03 |
| ES2275945T3 (es) | 2007-06-16 |
| BR0215154A (pt) | 2004-10-19 |
| CO5590925A2 (es) | 2005-12-30 |
| MA27149A1 (fr) | 2005-01-03 |
| EP1461034A1 (de) | 2004-09-29 |
| RS53204A (en) | 2006-10-27 |
| DE50208809D1 (de) | 2007-01-04 |
| RU2004122415A (ru) | 2005-03-27 |
| HUP0600836A2 (en) | 2008-04-28 |
| MXPA04005388A (es) | 2004-10-11 |
| JP4571803B2 (ja) | 2010-10-27 |
| WO2003053434A1 (de) | 2003-07-03 |
| JP2005516947A (ja) | 2005-06-09 |
| IL162562A (en) | 2009-12-24 |
| DK1461034T3 (da) | 2007-03-26 |
| TW200305408A (en) | 2003-11-01 |
| KR100959031B1 (ko) | 2010-05-20 |
| CN100339079C (zh) | 2007-09-26 |
| AU2002361990B2 (en) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20035298D0 (no) | CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler | |
| NO20040356L (no) | Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling. | |
| NO20033726L (no) | Xantin-derivater, fremstilling og anvendelse derav som et medikament | |
| DK1445252T3 (da) | Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter | |
| DK1549341T3 (da) | Mod vævsfaktor rettede antistoffer som antikoagulanter | |
| NO20052496D0 (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter. | |
| NO20031273L (no) | Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme | |
| NO20032438L (no) | Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene | |
| DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
| ITMI20020622A1 (it) | Perno di fissaggio per membrana di rigenerazione di tessuti dentali | |
| NO20025879L (no) | Acylfenylureaderivater, fremgangsmåter for fremstilling derav og deres anvendelse som legemiddel | |
| NO20011503L (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler | |
| NO20042635L (no) | 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin | |
| NO20041785L (no) | Farmasoytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt | |
| NO20005146L (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
| DK1322158T3 (da) | Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf | |
| NO20040860L (no) | Farmasoytisk sammensetning som innbefatter lumiracoxib | |
| NO20022801D0 (no) | Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse | |
| NO20040210L (no) | Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler | |
| NO20043009L (no) | Substituerte imidazolidiner, fremgangsmate for fremstilling derav, deres anvendelse som et legemiddel eller for diagnose og legemiddel inneholdende substituerte imidazolidiner | |
| DK1064284T3 (da) | Hypnotiske beta-carbolinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse som medicinske produkter | |
| IL173546A0 (en) | Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them | |
| NO20045504L (no) | Substituerte tiofener, fremgangsmate for fremstilling, deres anvendelse som medikament eller diagnostisk middel samt et medikament inneholdende disse | |
| IL175237A0 (en) | Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same | |
| ITTO20030850A1 (it) | Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |